- Home
- BCAL vs OVID Comparison
BCAL vs OVID Comparison
Compare BCAL & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCAL | OVID |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.3M | 522.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BCAL | OVID |
|---|---|---|
| Price | $19.02 | $2.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $20.67 | $4.60 |
| AVG Volume (30 Days) | 138.5K | ★ 1.7M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 777.27 | 3.90 |
| EPS | ★ 0.42 | N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.67 | $19.34 |
| P/E Ratio | $45.26 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $14.07 | $0.27 |
| 52 Week High | $20.47 | $3.11 |
Technical Indicators
Market Signals| Indicator | BCAL | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 42.00 |
| Support Level | $18.49 | $1.95 |
| Resistance Level | $19.26 | $2.72 |
| Average True Range (ATR) | 0.35 | 0.16 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 68.09 | 20.45 |
Price Performance
Historical ComparisonAbout BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.